Accepted at 1:04 a.m. Nov, 01, 2023 by dollajas
Author: Aaron
Related Note: 1484950290832
Rationale for change

Not a primary treatment option. Note referencing risk added to extra.

Text Text
Extra
Opiates may reduce anxiety and distress associated with dyspnea but also may induce nausea and depress respiratory drive. May also decrease SVR/BP

*Due to limited evidence of benefit and some concerns about potential harm, UTD and AMBOSS do not generally recommend opiates for treatment of dyspnea attributed to acute pulmonary edema (CHF) (May 2023)
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid

Sketchy


Watch Opioids, Naloxone, Naltrexone
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize

Physeo

Bootcamp
Watch associated Bootcamp video - Substance Misuse : Opioids
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#Pixorize::03_Pharmacology::16_Other_Neuro_Pharm::17_Full_Opioid_Agonists #AK_Step1_v12::#FirstAid::12_Neurology_and_Special_Senses::06_Pharm::14_Opioid_analgesics !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::^Other::^HighYield::4-LowerYield #AK_Step1_v12::#OME::Clinical::Pediatrics/Psychiatry #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Bootcamp::Psychiatry::08_Substance_Misuse::03_Opioids #AK_Step1_v12::#Physeo::09_Pharm::14_Neuro::21_Opioid_Clinical_Use,_Mechanism_and_Overdose #AK_Step1_v12::#B&B::17_Psych::03_Substance_Use_Disorders::02_Opioids::Extra #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::01_Anesthetics_&_Analgesics::03_Opiates,_Naloxone,_Naltrexone #AK_Step1_v12::^Systems::Neuro::Pharmacology